Analysis of the activated partial thromboplastin time test using mathematical modeling

被引:38
作者
Kogan, AE
Kardakov, DV
Khanin, MA
机构
[1] Moscow MV Lomonosov State Univ, Fac Biol, Dept Biochem, Moscow 119899, Russia
[2] Russian State Univ Technol, Lab Theoret Biol, Moscow, Russia
关键词
APTT test; mathematical modeling; contact activation;
D O I
10.1016/S0049-3848(00)00405-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activated partial thromboplastin time (APTT) is a laboratory test for the diagnosis of blood coagulation disorders. The test consists of two stages: The first one is the preincubation of a plasma sample with negatively charged materials (kaolin, ellagic acid etc.) to activate factors XII and XI; the second stage begins after the addition of calcium ions that triggers a chain of calcium-dependent enzymatic reactions resulting in fibrinogen clotting. Mathematical modeling was used for the analysis of the APTT test. The process of coagulation was described by a set of coupled differential equations that were solved by the numerical method. It was found that as little as 2.3 x 10(-9) muM of factor XIIa (1/10 000 of its plasma concentration) is enough to cause the complete activation of factor XII and prekallikrein (PK) during the first 20 s of the preincubation phase. By the end of this phase, kallikrein (K) is completely inhibited, residual activity of factor XIIa is 54%, and factor XI is activated by 26%. Once a clot is formed, factor II is activated by 4%, factor X by 5%, factor IX by 90%, and factor XI by 39%. Calculated clotting time using protein concentrations found in the blood of healthy people was 40.5 s. The most pronounced prolongation of APTT is caused by a decrease in factor X concentration. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:299 / 310
页数:12
相关论文
共 74 条
[1]  
ATAULLAHANOV FI, 1994, BIOFIZIKA+, V39, P713
[2]  
ATAULLAKHANOV FI, 1995, BIOFIZIKA+, V40, P434
[3]  
BAJAJ SP, 1982, J BIOL CHEM, V257, P4127
[4]  
BEATTY K, 1980, J BIOL CHEM, V255, P3931
[5]  
BERRETTINI M, 1989, J BIOL CHEM, V264, P11738
[6]  
BOUMA BN, 1977, J BIOL CHEM, V252, P6432
[7]   An integrated study of fibrinogen during blood coagulation [J].
Brummel, KE ;
Butenas, S ;
Mann, KG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) :22862-22870
[8]  
BRUNNEE T, 1993, BLOOD, V81, P580
[9]   METABOLISM OF ANTITHROMBIN-3 (HEPARIN COFACTOR) IN MAN - EFFECTS OF VENOUS THROMBOSIS AND OF HEPARIN ADMINISTRATION [J].
COLLEN, D ;
SCHETZ, J ;
DECOCK, F ;
HOLMER, E ;
VERSTRAETE, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1977, 7 (01) :27-35
[10]   INITIATION OF BLOOD-COAGULATION AT ARTIFICIAL SURFACES [J].
COLMAN, RW ;
SCOTT, CF ;
SCHMAIER, AH ;
WACHTFOGEL, YT ;
PIXLEY, RA ;
EDMUNDS, LH .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 516 :253-267